Funding for this research was provided by:
Ministry of Science Research and Technology (Excellence for Cancer Research Center), Taiwan (MOST105-2325-B-037-001)
Ministry of Health and Welfare, Taiwan (MOHW106-TDU-B-212-144007)
Health and Welfare Surcharge of Tobacco Products, Taiwan
Kaohsiung Medical University Hospital, Taiwan (KMUH104-4M25, KMHU105-5M21, KMUHS10522, KMUHS10505, KMUHS10518, and KMUHGCRC2016002)
Kaohsiung Medical University “Aim for the Top 500 Universities Grant” (KMU-TP105C01, KMU-TP105C11)
Kaohsiung Medical University “Aim for the Top University Grant” (KMU-TP105A14, KMU-DK106005, and SH000113 (Give2Asia))
Grant of Biosignature in Colorectal Cancers, Academia Sinica, Taiwan
Received: 30 May 2017
Accepted: 23 January 2018
First Online: 31 January 2018
Ethics approval and consent to participate
: This study was approved by the Institutional Review Board of Kaohsiung Medical University Hospital (KMUH-IRB 1217–1417).
: Not applicable as this is a retrospective review of two expired patients.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.